Funding
Accelerator investment · Healthtech

HEURIS secures BGV backing for clinical reasoning support

HEURIS develops clinical reasoning software that helps emergency care teams examine diagnostic uncertainty and consider overlooked explanations.

By RoundOS Funding desk

Bethnal Green Ventures named HEURIS among the companies joining its Spring 2026 investment portfolio on April 21. The investment is part of BGV's Tech for Good programme for early-stage businesses.

Reasoning support for emergency care

HEURIS develops software for clinicians assessing patients in emergency care. The tool reviews assessment input and flags potentially overlooked features or explanations, helping clinical teams consider uncertainty before reaching a decision.

Funding history

Accelerator investment · This roundUndisclosed

Sources

  1. Announcing our Spring 2026 cohortbethnalgreenventures.com · Apr 21, 2026
  2. heurishealth.com
  3. find-and-update.company-information.service.gov.uk

Similar rounds

All Healthtech rounds →
Nanochap

Develops retinal and cortical brain-computer interfaces that use electrical stimulation to create artificial visual perception.

CN¥500MSeries C+ · Nov 3, 2026
1nhaler

1nhaler develops a compact, single-dose dry powder inhaler made predominantly from cardboard.

£2.2MFollow-on funding · Nov 3, 2026
Esonitro

Esonitro develops flexible neural electrodes and brain-computer interface technology, including its movable NeuroWorm electrode.

~CN¥100MAngel+ · Nov 2, 2026
OBSESS

OBSESS connects people with sports venues, gyms, trainers, nutrition providers and fitness brands through a shared digital marketplace.

~₹30MAngel · Nov 2, 2026

Related